Alcohol Consumption Among HIV-Infected Women: Impact on Time to Antiretroviral Therapy and Survival

被引:51
|
作者
Neblett, Robyn C. [1 ]
Hutton, Heidi E. [2 ]
Lau, Bryan [3 ]
McCaul, Mary E. [2 ]
Moore, Richard D. [1 ]
Chander, Geetanjali [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
[3] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
IDENTIFICATION TEST AUDIT; UNITED-STATES; TEMPORAL RELATIONSHIP; GENDER-DIFFERENCES; HEPATITIS-C; ADHERENCE; MORTALITY; COHORT; NONADHERENCE; PREDICTORS;
D O I
10.1089/jwh.2010.2043
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Alcohol use is prevalent among HIV-infected people and is associated with lower antiretroviral adherence and high-risk sexual and injection behaviors. We sought to determine factors associated with alcohol use among HIV-infected women engaged in clinical care and if baseline alcohol use was associated with time to combination antiretroviral therapy (cART) and death in this population. Methods: In an observational clinical cohort, alcohol consumption at the initial medical visit was examined and categorized as heavy, occasional, past, or no use. We used multinomial logistic regression to test preselected covariates and their association with baseline alcohol consumption. We then examined the association between alcohol use and time to cART and time to death using Kaplan-Meier statistics and Cox proportional hazards regression. Results: Between 1997 and 2006, 1030 HIV-infected women enrolled in the cohort. Assessment of alcohol use revealed occasional and hazardous consumption in 29% and 17% of the cohort, respectively; 13% were past drinkers. In multivariate regression, heavy drinkers were more likely to be infected with hepatitis C than nondrinkers (relative risk ratios [RRR] 2.06, 95% confidence interval [CI] 1.29-3.44) and endorse current drug (RRR 3.51, 95% CI 2.09-5.91) and tobacco use (RRR 3.85 95% CI 1.81-8.19). Multivariable Cox regression adjusting for all clinical covariates demonstrated an increased mortality risk (hazard ratio [HR] 1.40, 95% CI 1.00-1.97, p < 0.05) among heavy drinkers compared to nondrinkers but no delays in cART initiation (1.04 95% CI 0.81-1.34) Conclusions: Among this cohort of HIV-infected women, heavy alcohol consumption was independently associated with earlier death. Baseline factors associated with heavy alcohol use included tobacco use, hepatitis C, and illicit drug use. Alcohol is a modifiable risk factor for adverse HIV-related outcomes. Providers should consistently screen for alcohol consumption and refer HIV-infected women with heavy alcohol use for treatment.
引用
收藏
页码:279 / 286
页数:8
相关论文
共 50 条
  • [21] Staging for antiretroviral therapy among HIV-infected drug users
    Wood, E
    Hogg, RS
    Bonner, S
    Kerr, T
    Li, K
    Palepu, A
    Guillemi, S
    Schechter, MT
    Montaner, JSG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (10): : 1175 - 1177
  • [22] Antiretroviral therapy of HIV-infected patients
    Gölz, J
    [J]. MEDIZINISCHE WELT, 1999, 50 (06): : 223 - 229
  • [23] Antiretroviral therapy in HIV-infected children
    Fan, Conghai
    Zhang, Fengchao
    Chen, Chao
    [J]. MINERVA PEDIATRICA, 2019, 71 (05) : 455 - 460
  • [24] Alcohol Types and HIV Disease Progression Among HIV-Infected Drinkers Not Yet on Antiretroviral Therapy in Russia and Uganda
    Asiimwe, Stephen B.
    Fatch, Robin
    Patts, Gregory
    Winter, Michael
    Lloyd-Travaglini, Christine
    Emenyonu, Nneka
    Muyindike, Winnie
    Kekibiina, Allen
    Blokhina, Elena
    Gnatienko, Natalia
    Kruptisky, Evgeny
    Cheng, Debbie M.
    Samet, Jeffrey H.
    Hahn, Judith A.
    [J]. AIDS AND BEHAVIOR, 2017, 21 (02) : S204 - S215
  • [25] Alcohol Types and HIV Disease Progression Among HIV-Infected Drinkers Not Yet on Antiretroviral Therapy in Russia and Uganda
    Stephen B. Asiimwe
    Robin Fatch
    Gregory Patts
    Michael Winter
    Christine Lloyd-Travaglini
    Nneka Emenyonu
    Winnie Muyindike
    Allen Kekibiina
    Elena Blokhina
    Natalia Gnatienko
    Evgeny Kruptisky
    Debbie M. Cheng
    Jeffrey H. Samet
    Judith A. Hahn
    [J]. AIDS and Behavior, 2017, 21 : 204 - 215
  • [26] Impact of HIV testing on uptake of HIV therapy among antiretroviral naive HIV-infected injection drug users
    Wood, Evan
    Kerr, Thomas
    Hogg, Robert S.
    Palepu, Anita
    Zhang, Ruth
    Strathdee, Steffanie A.
    Montaner, Julio S. G.
    [J]. DRUG AND ALCOHOL REVIEW, 2006, 25 (05) : 451 - 454
  • [27] Association of aging and survival in a large HIV-infected cohort on antiretroviral therapy
    Bakanda, Celestin
    Birungi, Josephine
    Mwesigwa, Robert
    Ford, Nathan
    Cooper, Curtis L.
    Au-Yeung, Christopher
    Chan, Keith
    Nachega, Jean B.
    Wood, Evan
    Hogg, Robert S.
    Dybul, Mark
    Mills, Edward J.
    [J]. AIDS, 2011, 25 (05) : 701 - 705
  • [28] Impact of Antiretroviral Therapy on Incidence of Pregnancy among HIV-Infected Women in Sub-Saharan Africa: A Cohort Study
    Myer, Landon
    Carter, Rosalind J.
    Katyal, Monica
    Toro, Patricia
    El-Sadr, Wafaa M.
    Abrams, Elaine J.
    [J]. PLOS MEDICINE, 2010, 7 (02)
  • [29] Antiretroviral therapy in HIV-infected children: The metabolic cost of improved survival
    Leonard, EG
    McComsey, GA
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2005, 19 (03) : 713 - +
  • [30] Prenatal Care and Antiretroviral Therapy Use during Pregnancy among HIV-Infected Women on Medicaid
    Phiri, Kelesitse
    Williams, Paige L.
    Dugan, Katherine B.
    Cooper, William O.
    Seage, George R.
    Hernandez-Diaz, Sonia
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 378 - 378